0001144204-11-061510.txt : 20111104 0001144204-11-061510.hdr.sgml : 20111104 20111104210338 ACCESSION NUMBER: 0001144204-11-061510 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111102 FILED AS OF DATE: 20111104 DATE AS OF CHANGE: 20111104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Robin L CENTRAL INDEX KEY: 0001365035 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 111182588 MAIL ADDRESS: STREET 1: C/O PHASE III MEDICAL, INC. STREET 2: 330 SOUTH SERVICE ROAD, SUITE 120 CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeoStem, Inc. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-584-4171 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE DATE OF NAME CHANGE: 20030819 FORMER COMPANY: FORMER CONFORMED NAME: CORNICHE GROUP INC /DE DATE OF NAME CHANGE: 19951117 FORMER COMPANY: FORMER CONFORMED NAME: FIDELITY MEDICAL INC DATE OF NAME CHANGE: 19951025 4 1 v239283_4.xml OWNERSHIP DOCUMENT X0304 4 2011-11-02 0 0000320017 NeoStem, Inc. NBS 0001365035 Smith Robin L C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450 NEW YORK NY 10170 1 1 0 0 Chairman of Board and CEO Common Stock, $0.001 par value 2011-11-02 4 A 0 268664 0.62 A 1332750 D On November 2, 2011, the Compensation Committee of the Issuer's Board of Directors approved an arrangement whereby the Reporting Person shall receive the net amount of her contractual bonus due October 1, 2011, through the issuance to her by the Issuer of shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), at the closing price of the Common Stock on November 1, 2011, under and subject to the terms and conditions of the Issuer's 2009 Equity Compensation Plan. Robin L. Smith By: /s/ Catherine M. Vaczy, Esq., Attorney-in-Fact 2011-11-04